Citation Impact
Citing Papers
Base-excision repair of oxidative DNA damage
2007 StandoutNature
Current oral treatments for erectile dysfunction
2002
Emerging Pharmacologic Approaches for the Treatment of Lower Urinary Tract Disorders
2004
Parkinson disease
2017 Standout
Quantification of mRNA using real-time RT-PCR
2006 Standout
The Female Sexual Function Index (FSFI): Cross-Validation and Development of Clinical Cutoff Scores
2005 Standout
Hereditary non-polyposis colorectal cancer: The rise and fall of a confusing term
2006
Hereditary colorectal cancer syndromes
2005
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
2014 Standout
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
2009 Standout
Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
2011
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents
2005 Standout
Pre-PCR Processing : Strategies to Generate PCR-Compatible Samples
2004
Genetic pathways in colorectal and other cancers
1999
Silymarin, the antioxidant component and Silybum marianum extracts prevent liver damage
2009
The genetics of FAP and FAP-like syndromes
2006
Lynch Syndrome Patients with Limited Family History Identified in a Laboratory Setting: A Descriptive Study
2015 Standout
Natural and iatrogenic variation in hepatitis B virus
1999
Management of Hepatocellular Carcinoma *
2005 Standout
The International Index of Erectile Function (IIEF): a state-of-the-science review
2002
Inflammation and Colon Cancer
2010 Standout
Central nervous system-acting agents and the treatment of erectile and sexual dysfunction
2007
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Chronic hepatitis B
2007 Standout
Mutants of Taq DNA polymerase resistant to PCR inhibitors allow DNA amplification from whole blood and crude soil samples
2009
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics
2009
Hereditary Colorectal Cancer
2003 Standout
The genetics of hereditary colon cancer
2007
Non-motor features of Parkinson disease
2017 Standout
The ChEMBL database in 2017
2016 Standout
Oncogenic DNA viruses
2001 StandoutNobel
ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers
2016
Global Patterns of Cancer Incidence and Mortality Rates and Trends
2010 Standout
Adenosine
2014
Exposure to Low-Dose Ionizing Radiation from Medical Imaging Procedures
2009 Standout
Hamartomatous Polyposis Syndromes
2008
An analysis of the attrition of drug candidates from four major pharmaceutical companies
2015 Standout
Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors
2019 Standout
Hepatitis B virus precore mutants in serum and liver of Southern African Blacks with hepatocellular carcinoma
1998
PCR inhibitors - occurrence, properties and removal
2012 Standout
Hepatitis B virus and hepatocellular carcinoma
2001
Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature.
2002
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
The Role of Oxidative Stress and Antioxidants in Liver Diseases
2015 Standout
Ca2+Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase
2003 Standout
RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase
2013 StandoutNobel
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Serum ?-L-fucosidase activity and early detection of hepatocellular carcinoma
1998
Prediction of the Development of Hepato-Cellular-Carcinoma in Patients with Liver Cirrhosis by the Serial Determinations of Serum Alpha-L-fucosidase Activity.
1999
Serum α-L-fucosidase activity and tumor size in hepatocellular carcinoma
1994
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
2015 Standout
Works of Stan Bukofzer being referenced
A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease
2012
Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: a prospective, randomized, multicenter study
2014
A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease
2012
Nucleic Acid Sequence Analysis of the Precore Region of Hepatitis B Virus From Sera of Southern African Black Adult Carriers of the Virus
1997
Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in southern African blacks
1989
A European multicentre study to evaluate the tolerability of apomorphine sublingual administered in a forced dose‐escalation regimen in patients with erectile dysfunction
2002
Clinical and molecular features of the hereditary mixed polyposis syndrome
1997
Double–Blind, Crossover Comparison of 3 mg Apomorphine SL with Placebo and with 4 mg Apomorphine SL in Male Erectile Dysfunction
2001
Comparison of hepatitis B virus DNA extractions from serum by the QIAamp blood kit, GeneReleaser, and the phenol-chloroform method
1996